Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients

International Journal of Clinical Practice

Volumn 59, Issue 10, 2005, Pages 1137-1142

  Degirmenci, Irfan ^a   Kebapci, N ^a   Basaran, A ^a   Efe, B ^a   Gunes, H V ^a   Akalin, A ^a   Kurt, H ^a   Urhan, M ^b   Demirustu, C ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

ACE gene polymorphism; Nephropathy; PCR; Type 2 diabetes mellitus

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SPECTROPHOTOMETRY; TURKEY (REPUBLIC); AGED; BLOOD; DIABETES MELLITUS; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 33644848644     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00586.x     Document Type: Article

References (33)

1. Tiret L, Rigat B, Visvikis S et al. Evidence from combined segregation and linkage analysis, that a variant of angiotensin I converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
2. Rasmussen LM, Ledet T. Aortic atherosclerosis in diabetes mellitus is associated with an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Diabetologia 1996; 39: 696-700.
3. Huang X-H, Rantalaiho V, Wirta O et al. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 1998; 102: 372-8.
4. Kimura H, Gejyo F, Suzuki Y et al. Polymorphism of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy. Kidney Int 1998; 54: 1659-69.
5. Doi Y, Yoshizumi H, Yoshinari M et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102.
6. Chuang LM, Chiu KC, Chiang FT et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 1999; 46: 1211-4.
7. Cambien F, Costerousse O, Tiret L et al. Plasma level and gene polymorphism of angiotensin-converting enzyme gene in relation to myocardial infarction. Circulation 1994; 90: 669-76.
8. Hubert C, Houot A-M, Corvol P et al. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266: 15377-83.
9. Yoshida H, Kuriyama S, Atsumi Y et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657-64.
10. Miura J, Uchigata Y, Yokoyama H et al. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1999; 45: 41-9.
11. Panahloo A, Andres C, Ali VM et al. The insertion allele of the ACE gene I/D polymorphism. Circulation 1995; 92: 3390-3.
12. Rudberg S, Rasmussen L, Bangstad HJ et al. Influence of I/D polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type I diabetic patients with microalbuminuria. Diabetes Care 2000; 23: 544-8.
13. De Azevedo MJ, Dalmaz CA, Caramori MLA et al. ACE and PC-1 gene polymorphism in normoalbuminuric type 1 diabetic patients. A 10-year prospective study. Diabetes Res Clin Pract 2002; 16: 255-62.
14. Araz M, Yýlmaz N, Gungor K et al. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 2001; 54: 95-104.
15. Braunwald E, Hauser SL, Fauci AI (eds). Principle of Internal Medicine, 15th edn. New York: McGraw-Hill, 2001-2122.
16. Tomita H, Ina Y, Sugiura Y et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis. Am J Respir Crit Care Med 1997; 156: 255-9.
17. Marre M, Jeunemaitre X, Gallois Y et al. Contribution of genetic polymorphism in the rennin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997; 99: 1585-95.
18. Akar N, Aras O, Omurlu K, Cin S Deletion polymorphism at the angiotensin-converting enzyme gene in Turkish patients with coronary artery disease. Scand J Clin Lab Invest 1998; 58: 491-5.
19. Yenigun M, Altuntas Y. Her Yonuyle Diabetes Mellitus 2. Baski, Istanbul: Nobel Tip Kitabevi, 2001: 78-80.
20. Porte D, Sherwin RS. Ellenberg and Rifkin's Diabetes Mellitus, 5th edn. Stamford: Elsevier Science Publishing Co, 1997: 384-7.
21. Young RP, Chan JC, Cruthley JA et al. Angiotensinogen T235 and ACE I/D polymorphism associated with microalbuminuria in Chinese type 2 diabetic patients. Diabetes Care 1998; 21: 431-7.
22. Ueda S, Elliot HL, Morton JJ et al. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25: 1266-9.
23. Van Ittersum FJ, De Man AM, Thijssen S. Genetic polymorphism of the renin-angiotensin system and complication of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000; 15: 1000-7.
24. Leehey DJ, Singh AK, Alavi N et al. Role of angiotensin II in diabetic nephropathy. Kidney Int 2000; 58 (Suppl. 77): S93-S98.
25. Wu S, Xiang K, Weng Q et al. Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy. Chin Med J (Engl) 1998; 111: 478-9.
26. Gumprecht J, Zychma MJ, Grzeszczak W et al. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. Kidney Int 2000; 58: 513-9.
27. Araz M, Okan V, Celen Z et al. Angiotensin-converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients. Int J Clin Pract 2002; 56: 416-8.
28. Agerholm-Larsen B, Nordestgaard BG, Tybjærg-Hansen A. ACE gene polymorphism in cardiovascular disease. Arterioscler Thromb Vasc Biol 2000; 20: 484-92.
29. Matsumoto A, Iwashima Y, Abiko A et al. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I converting enzyme and advanced diabetic retinopathy. Diabetes Res Clin Pract 2000; 50: 195-202.
30. Malik RA, Williamson S, Abbott C et al. Effect of angiotensin converting enzyme inhibitor trandolapril on human diabetic neuropathy: Randomised double-blind controlled trial. Lancet 1998; 352: 1978-81.
31. Ito H, Tsukui S, Kanda T et al. Angiotensin-converting enzyme I/D polymorphism and polyneuropathy in type 2 diabetes without macroalbuminuria. J Int Med Res 2002; 30: 476-82.
32. Taniwaki H, Ishimura E, Matsumoto N et al. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 2001; 24: 1653-60.
33. Nagi DK, Mansfield MW, Stickland MH et al. Angiotensin-converting enzyme gene polymorphism and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med 1995; 12: 997-1001.